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CHAPTER I
REVIEW OF LITERATURE

Melatonin
American physician, Aaron B. Lerner, at Yale University School of Medicine,
first discovered melatonin in 1958. Melatonin (N-actyl-5-methoxytryptamine) is a
hormone that is secreted by the pineal gland, which is located at the center of the brain.
Melatonin has various effects on the physiological system, which is illustrated in Fig. 1.
Melatonin plays an important role in circadian rhythm and is influenced by light and dark
detections by the retina (Richter et al. 2009). Melatonin increases blood flow to the fetus
(Lemley et al. 2013). This hormone is unique as it has the ability to protect the body
against free radicals via direct or indirect pathways (Reiter et al. 1995). Melatonin can
bind directly to cellular membranes and aid in the stabilization of the membrane against
possible oxidative damage, and it has the ability to protect cells indirectly by helping the
body up-regulate its own antioxidant defense system (Reiter et al. 1995). Imbalances
between reactive oxygen specie production and antioxidant systems could have a
negative impact by creating oxidative stress which, in turn, can negatively impact the
reproductive process. With reactive oxygen specie levels being increased during
pregnancy, oxidative stress is directly related to several pregnancy disorders, such as
spontaneous abortions, embryopathies, preeclampsia, fetal growth restriction, preterm
labor, and low birth weight (Kaïs et al. 2010). The links between oxidative stress, the
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female reproductive system, and the development of negative pregnancy outcomes results
in important concerns in both human and animal reproductive sciences (Kaïs et al 2010).
Fetal Programming
Seventy-five percent of the growth of the ruminant fetus occurs during the last
two months of gestation (Robinson et al. 1977). With this in mind, researchers
hypothesized that variation in maternal intake would have effects on a variety of
production characteristics during late gestation (Funston et al. 2009). Findings by Larson
et al. (2009) observed that late gestation protein supplementation and increased global
nutrient supply increased calf weaning weights from 225 kg in the non-supplemented to
247 kg in the protein supplemented dams. Martin et al. (2007) also provided a protein
supplement during the last one-third of gestation but birth weights of calves were not
different from those that were not supplemented. However, weights pre-breeding were
greater for heifers from protein-supplemented dams (Martin et al. 2007).
Most fetal programming studies use the model of undernutrition or overnutrition
during a critical window of gestation. Restriction during early gestation appears to affect
placental development and vascularity, where restriction during late gestation is likely
affecting final development of organ systems and nutrient uptake by tissues that are
important for growth and reproduction (Vonnahme et al. 2007; Lemley et al. 2012).
A study by Nissen et al. (2003) in pregnant sows had three treatment groups,
which included 1) control feeding, 2) ad libitum feeding from day 25 to 50 of gestation,
and 3) ad libitum feeding from day 24 to 70 of gestation. This study found no effect of
treatment on meat quality traits in the offspring (Nissen et al. 2003). With these findings,
it is clear that increasing maternal nutrition does not have a programming effect on the
2

offspring for either increased meat quality traits or growth characteristics. The fetal
period is critical for skeletal muscle development as there is no net increase in the
number of muscle fibers following birth (Glore & Layman 1993; Greenwood et al. 2000;
Nissen et al. 2003).
While undernutrition can alter uteroplacental development, overfeeding is also of
great alarm as some of the same physiological and endocrine responses occur. Reynolds
et al. (2006) explains that experimental conditions designed to investigate intrauterine
growth restriction and placental efficiency, whether it be through overnutrition, nutrient
restriction, hyperthermia, or high altitude, commonly cause reduced uterine and umbilical
blood flow. In the overfed pregnant adolescent ewe, uterine blood flow was reduced by
56% at day 90 of gestation, which was before any reduction in fetal or placental weights
were observed (Wallace et al. 2005). Thus, overfeeding the dam can lead to a reduction in
blood flow, which could have a permanent response in the blood flow of the offspring.
Nitric oxide is an endothelium derived vasorelaxing factor that plays a key role in
the regulation of uteroplacental blood flow (Bird et al. 2003). When free radicals exceed
the body’s antioxidant production capacity, the result is oxidative stress (Castillo et al.
2004). Specifically in dairy cattle, the peripartum and early lactation periods are
especially crucial and present considerable physiological challenges to homeostasis by
imposing significant metabolic stressors that could contribute to the onset of various
disorders (Goff & Horst 1997). Castillo et al. (2005) evaluated oxidative status by
analyzing total antioxidant capacity in healthy cows during late pregnancy and lactation
onset. Castillo et al. (2005) found that total antioxidant capacity peaked one week after
calving followed by a decline thereafter. With total antioxidant capacity peaking one
3

week after calving, this could possibly lead to an increase in milk letdown of the dam, as
oxidative stress is decreased one week post calving.
Numerous livestock models have been used for fetal programming in an attempt
to further investigate fetal programming implications in humans. A study in humans
observed that low birth weight has been consistently associated with coronary heart
disease and type 2 diabetes (Barker et al. 2002). The effects of low birth weight can be
slow infant growth and rapid postnatal weight gain during childhood, which can increase
the risk of coronary heart disease and type 2 diabetes (Barker et al. 2002). Barker et al.
(2002) found that men and women who had birth weights above 4 kg had around half the
risk of type 2 diabetes and hypertension when compared to people who had birth weights
below 3 kg. These findings could be a result of a negative insult during pregnancy, which
can then be programmed in the offspring and have a negative effect on childhood or adult
health. With coronary heart disease and type 2 diabetes being two of the most abundant
diseases in humans, additional research in fetal programming is crucial in the area of
human medicine.
Antioxidant Effects of Melatonin
The relationship between melatonin and total antioxidant capacity is a recent
concept that has not been extensively researched until the last fifteen years. Melatonin is
an antioxidant that has the ability to affect genomic actions, regulation of expression of
genes, antioxidant enzyme activity, and cellular mRNA levels of enzymatic activity.
Melatonin is endogenously produced from the pineal gland and scavenges reactive
oxygen and nitrogen species (Reiter et al. 2001). Melatonin also plays a pivotal role in
the up-regulation of antioxidant pathways (Richter et al. 2009). A number of melatonin
4

receptors have been identified in mammalian species; however, further research is needed
to better understand melatonin receptor pathways.
Antioxidant enzymes form the first line of defense against free radicals
(Rodriguez et al. 2003). When equilibrium is unbalanced between free radicals (oxidants)
and antioxidant defense systems with the balance favoring oxidants, oxidative stress is
formed (Rodriguez et al. 2003). The mechanism by which these antioxidants fight these
reactants is by metabolizing them to innocuous byproducts (Rodriguez et al. 2003).
The most abundant reactive oxygen species (ROS) formed in cellular metabolism
is the superoxide radical (Rodriguez et al. 2003). Hydrogen peroxide is a product of the
of the superoxide anion radical (Reiter et al. 2001). Hydrogen peroxide is not considered
a highly reactive agent although; it does have the ability to deactivate certain enzymes
(Reiter et al. 2001). A major drawback associated with hydrogen peroxide is its ability to
readily cross cell membranes (Reiter et al. 2001). The result of this would be the
spreading of additional ROS.
Although the superoxide radical is the most abundant ROS, the hydroxyl radical
is the most damaging (Reiter et al. 2001). The destructive actions that the hydroxyl
radical produce are typically measured by oxidatively mutilated lipids, proteins, and
DNA (Reiter et al. 2001). The hydroxyl radical is such a reactive radical that its diffusion
distance is limited (Reiter et al. 2001). Based off this observation, the damage done by
the hydroxyl radical appears to be site-specific (Reiter et al. 2001). The results of this
damaging radical may lead to diseases such as cancer, neurodegeneration, and
autoimmune conditions (Rodriguez et al. 2003).
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Melatonin was tested in an attempt to rank its ability to scavenge the hydroxyl
radical. Hydrogen peroxide was exposed to 254 nm of ultraviolet light to produce the
hydroxyl radical (Reiter et al. 2001). These adducts were inhibited in the presence of
melatonin, thus the indole had scavenged the hydroxyl radical (Finkelstein et al. 1980).
There is a possibility that melatonin can act as a recycled antioxidant, which would
greatly increase its ability to reduce oxidative damage (Stasica et al. 1998).
Just as hydrogen peroxide can pass through cellular membranes with ease, the
same is true with nitric oxide. Nitric oxide is important in a plethora of biological
regulations within the body. Some of those regulations include blood pressure and
destruction of pathogens by immune cells (Snyder et al. 1992). Nitric oxide is a
hydrophobic, uncharged molecule that is produced from guanidine nitrogen of L-arginine
(Reiter et al. 2001). While nitric oxide has its beneficial properties, negative aspects of
nitric oxide are also present. Some of those deterrents are when excessive amounts of
nitric oxide are present; it has the ability to damage proteins (Moncada & Higgs et al.
1993; Radi et al. 1996). Nitric oxide also has the ability to damage DNA via protein
synthesis (Brune et al. 1994; Wink et al. 1991).
Melatonin plays a vital role in direct free radical scavenging (Tan et al. 1993), as
well as regulation of gene transcription (Steinhilber et al. 1995) for antioxidant enzymes.
A study was performed in which the pineal gland was surgically removed to analyze
melatonin concentrations present within the cells (Menendez-Paleaz et al. 1993; Tan et al.
1999). When analyzing this structure, melatonin was largely found in the nuclei and
cytosol (Menendez-Paleaz et al. 1993; Tan et al. 1999). These findings are consistent
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with the protection of nuclear DNA against oxidative damage (Menendez-Paleaz et al.
1993; Finnochiarro et al. 1998).
Melatonin can act as an antioxidant when used as a cell protector against diseases.
The first publication supporting melatonin having an influence on antioxidant activity
was in the mid-1990s (Barlow-Waldon et al. 1995). Antioxidant enzyme activities are
known to exhibit endogenous rhythms under normal light:dark conditions (Rodriguez et
al. 2003). By manipulating photoperiod, these cycles could be circadian rhythmdependent (Albarran et al. 2001). If production of endogenous melatonin is altered by a
continuous amount of light offered, this will in turn abolish the nighttime rise in
antioxidant enzyme activity. According to Albarran et al. (2001) and Pablos et al. (1998),
a reduction in night-time activity will increase glutathione peroxidase and superoxide
dismutase (SOD) activities in chick tissues. If a decrease in endogenous serum melatonin
is observed, the results could lead to a decrease in antioxidant capacity in the resistance
of oxidative stress (Manev et al. 1996; Kilic et al. 1999).
Melatonin supplementation during pregnancy increases antioxidant enzyme
activity in the fetus (Rodriguez et al. 2003). Melatonin can pass all morphophysiological
barriers (Reiter et al. 2001). This finding is especially important during pregnancy as
melatonin can pass directly through the placenta and enter fetal cells (Okatani et al. 1998;
Wakatsuki et al. 1999). This phenomenon has been found in rats, sheep, and humans.
High doses of melatonin administered to pregnant rats caused an increase in the indole in
both rat brain and maternal serum (Okatani et al. 2001). Glutathione peroxidase and SOD
activities were also increased (Okatani et al. 2001). Thus, melatonin administration could
be helpful during times of increased oxidative stress such as pregnancy.
7

There is variation among studies seeking to understand if melatonin is dosage
dependent. According to Kotler et al. (1998), after administering either 50 or 500 μg/kg
of melatonin to rats, the lower dosage had a greater stimulatory effect on antioxidant gene
expression than the higher dosage. Antolin et al. (1996) reported that melatonin provided
protection against in vivo neurotoxicity using a dosage of 500 μg/kg in rats. These studies
provide support that both antioxidant enzyme activity and expression are elevated after
peripheral administration of melatonin (Kotler et al. 1998; Antolin et al. 1996).
Ultrasonography
Doppler Frequency
Doppler ultrasonography has been an evolving piece of technology within the last
decade. Doppler ultrasonography can be used to measure blood flow. The ultrasound
machine is based off of Doppler-shift frequencies. These frequencies are defined as the
differences between the frequency of ultrasound waves and that of received echoes
(Ginther 2007). The shift frequencies are echoes from moving red blood cells either
increasing or decreasing in relation to them moving closer or further away from the
transducer. These red blood cells are moving at a speed of around 1 meter per second.
When the frequency results in a positive integer, the red blood cells are moving toward
the transducer. The result will be a negative integer when the red blood cells are moving
away from the transducer. The Doppler-shift frequencies from the red blood cells are
separated from other received echoes via demodulation.
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Transducers
Typically there are two types of transducers used: linear-array and convex array
transducers. The linear transducer depicts a rectangular view, whereas the convex array
depicts a pie-shaped field of view. The linear array is more frequently used in viewing a
large structure near to the transducer in one view (Ginther 2007). The advantage of the
convex transducer is ease of use because it is shorter and easier to manipulate.
Doppler Angle
The orientation in which the transducer is being used is crucial in Doppler
ultrasonography. If the image is on a part of the artery that transverse directly across, the
field of view will be an undesirable angle of 90° and will not be able to accurately detect
velocity of blood flow. If the artery is angled slightly towards the transducer, it will result
in a smaller and more desirable angle (Ginther 2007). The most desirable angles are
between 30° and 60° as this range is the greatest in velocity accuracy; however, this
range is also variable depending on the tissue being measured.
There is also a feature on the ultrasound that is an angle cursor, which can be used
to show the angle of intersection of the sound beams in relation to blood flow. It has been
estimated that an angle length of greater than or equal to 2 cm for placement of the angle
cursor is advantageous (Ginther 2007). If the tissue is difficult to see, it can result in a
cross section and the angle cannot be detected; therefore, the true velocity will not be
obtained. Both the shift frequency and Doppler angle are used for finding blood velocity.
Most often the desired measurements are computing systolic and diastolic measurements.
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Color-Doppler
Incorporating color into the Doppler technology is also possible. This is
commonly referred to as color flow or color-velocity imaging. This estimates blood
velocities from the Doppler shifts and angles. Brightness mode (gray scale or B-mode) is
normally used to identify and measure structures, but it also has the ability to diagnose
physiological status. When using B-mode, the shift frequencies are received from the
operator and are then transformed into color-coded spots representing blood flow. Each
color-scan line can consist of 8 to 10 Doppler cycles. One cycle represents one pulse
along with the resulting echoes. The echoes of the moving reflectors are computed in
order to find the average velocity and variance for each cycle. High frequency signals can
sometimes be detected. This is commonly referred to as noise and can usually be filtered
by settings on the ultrasound machine. Color-Doppler ultrasonography has been
impacting human medicine for more than two decades, but the implications that it can
have in the future are limitless.
Velocity Measurements
Each waveform represents one cardiac cycle. The maximum point is the systolic
velocity (s) and represents the maximum Doppler-shift frequency. The low point is the
diastolic velocity (d). A depiction of the waveform showing systolic velocity being the
maximum peak and diastolic being the lowest point of the waveform is represented in
Fig. 2. There are limitations with determining velocity. If the angle is not obtainable then
a true velocity cannot be computed. There is also not a plethora of information available
on the relationships of blood velocity and blood flow of the tissue supplied by the artery.
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Doppler Indices
Doppler indices are used to measure ratios that are computed from different points
on the spectrum. These are relative to the hemodynamics of the tissue that is being
supplied by the artery. An increase in resistance index (RI) or pulsatility index (PI)
values, indicates increased resistance and decreased perfusion to the distal tissues. When
using Doppler ultrasonography, the stationary object is the transducer, and the moving
reflectors are red blood cells. The RI is used because it is convenient to relate the
negative relationship between the degree of resistance in the tissue and the degree of
vascular perfusion. The greater the RI and PI, the lesser the perfusion.
Comparative Hemodynamic Techniques
Earlier studies used various techniques for measuring blood flow. Ferrell & Ford
(1980) quantitated blood flow during various stages of gestation in Hereford cows. The
technique performed was via electromagnetic blood flow probes that were placed in the
middle of the uterine artery. Indwelling catheters were also placed in an artery and vein
on the surface of the gravid horn. Blood flow measurements were recorded daily for 15
minutes. Blood samples were collected immediately following the blood flow
measurements. From days 178-199, 202-224, and 230-258, blood flow averaged 3.2
L/min, 3.9 L/min, and 3.1 L/min, respectively (Ferrell & Ford 1980). With this technique,
there are certain drawbacks that were recorded. Complete data were not recorded as some
of the blood flow transducers did not function properly (Ferrell & Ford 1980). Blood
flow to the pregnant horn became greater than could be accommodated by the blood flow
transducers and a blockage occurred to the uterine horn (Ferrell & Ford 1980). Catheters
also became inoperable in some cows (Ferrell & Ford 1980). It is important to record
11

these complications within the study as this affected retrieving a complete data set from
the study. The same laboratory later used a different technique, injection of deuterium
oxide, during late gestation. They observed that ipsilateral uterine artery blood flow at
day 226 was 2.9 L/min and at day 250 was 13.1 L/min (Reynolds 1986; Reynolds &
Ferrell 1987). Moreover, they observed a 4.5-fold increase in ipsilateral blood flow from
day 137-250 of gestation (Reynolds 1986; Reynolds & Ferrell 1987). Another
disadvantage to these techniques is that they were invasive and required surgical
procedures.
One of the first known studies to use Doppler ultrasonography was Bollwein et al.
(2001). Two Simmental cows and one Brown Swiss cow were used in the study to
analyze uterine artery hemodynamics. Both ipsilateral and contralateral uterine arteries
were scanned monthly. Blood flow was determined using the following variables: RI,
time-averaged maximum velocity, vessel diameter, and blood flow volume. Resistance
index was negatively correlated to all other variables measured; however, positive
correlations were found among time-average maximum velocity, vessel diameter, and
blood flow volume (Bollwein et al. 2001). As gestation progressed, the RI decreased
while vessel diameter and blood flow volume was increased (Bollwein et al. 2001). This
study was a foundational for future Doppler ultrasound studies involving uterine blood
flow. This is important to note as this technique is non-invasive.
Doppler ultrasonography has not only been performed in cattle but also in various
other species. Bollwein et al. (2004) used transrectal Doppler ultrasonography on four
mares measuring uterine and umbilical blood flow during pregnancy. Resistance index
and blood flow volume of the uterine arteries were evaluated every four weeks. Fetal
12

blood flow was measured every two weeks on the umbilical arteries using RI. There were
no significant differences found in uterine or umbilical blood flow (Bollwein et al. 2004).
The mean RI decreased during pregnancy and the mean volume increased almost 400fold from 69 ± 37 to 27,467 ± 8852 ml/min (Bollwein et al. 2004).
Both studies performed by Bollwein et al. (2001; 2004) are important to the future
of Doppler ultrasonography as both studies resulted in decreased RI as gestation
progressed and blood flow volume was increased with gestational day. Doppler
ultrasonography is a reliable technique as similar findings were found between the two
studies even though the studies were performed in different species.
A more recent study conducted by Herzog et al. (2011) performed Doppler
ultrasonography and measured uterine artery blood flow in cattle at days 203, 231, 259,
and 273 of gestation. This experiment observed a linear increase in total uterine artery
blood flow for all days (Herzog et al. 2011). It was also observed that heavier cows had a
greater increase in blood flow versus lighter cows (Herzog et al. 2011). Cows of similar
weight carrying heavy fetuses had increased blood flow compared to the light fetuses
(Herzog et al. 2011).
Since Doppler ultrasonography is such a new technology in research, a study by
Menzies-Gow and Marr (2007) was performed in Thoroughbred horses to show the
repeatability of using Doppler ultrasonography. According to Menzies-Gow and Marr
(2007) the technique is repeatable and sensitive enough to detect changes in blood flow
during both physiological and pathological states as well as following pharmacological
intervention. With the studies described, it appears the Doppler ultrasonography is
repeatable and accurate in blood flow measurements.
13

Conclusion
Melatonin is a hormone that needs further investigation. The mechanisms and
pathways in which melatonin functions as a physiological and pharmacological
antioxidant are still incomplete. The function and use of melatonin are still of great
interest.
Currently, melatonin has been studied as a feed supplement during both
compromised pregnancies as well as non-compromised pregnancies (Lemley et al. 2012).
With melatonin’s antioxidant properties, research is being conducted in the area of fetal
programming along with its effects on uterine artery blood flow. With studies showing an
increase in total uterine artery blood flow following melatonin supplementation to the
dam, there could be future implications of increased growth in the offspring by further
investigating blood distribution and physiological functions of various organs. Improved
organ function, as a result of fetal programming with melatonin exposure, could increase
longevity of livestock.
As previous researchers suggested, melatonin is a good antioxidant and can aid
during stressful time points. More research needs to be conducted in the area of
melatonin acting as an antioxidant to better realize its exact function. Melatonin along
with its oxidative properties could have a large impact on livestock production, as it is a
cost effective supplement costing 2 cents per head per day. With further research,
melatonin could have the possibility of being applicable in a production setting.
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Figure 1

Melatonin’s effect on physiological systems

Figure 2

Uterine artery blood flow in Holstein heifers

Uterine artery blood flow with angle cursor representing a 46° angle. The waveform below the image
represents a cardiac waveform with systolic being the peak of the waveform and diastolic being the trough
of the waveform. The waveform velocity is measured in cm/s, which is located at the bottom right of the
image. Blood flow is calculated by taking the mean velocity multiplied by the vessel area multiplied by 60
seconds.
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DIETARY MELATONIN ALTERS UTERINE ARTERY HEMODYNAMICS IN
PREGNANT HOLSTEIN HEIFERS

Introduction
The uterine environment during late gestation is vital for assuring a continual
delivery of sufficient oxygen and nutrients to the exponentially growing fetus. Based on
average lactation numbers in the United States, a Holstein female spends approximately
14% of their life within the uterus. Moreover, livestock used for meat production spend
an even larger amount of developmental time within the uterus, whereby the placenta is
their sole source of nourishment (Vonnahme & Lemley 2012; Redmer et al. 2004).
Melatonin supplementation during a compromised pregnancy may alter uteroplacental
blood flow through melatonergic receptor-mediated pathways or indirectly by decreasing
oxidative stress in the vascular system (Lemley et al. 2012; Lemley et al. 2013).
Melatonin is unique in that it has the ability to protect the body against free
radicals via direct or indirect pathways (Reiter et al. 1995). Firstly, melatonin can bind
directly to cellular membranes and help stabilize that membrane against possible
oxidative damage. Secondly, melatonin has the ability to protect cells indirectly by
helping the body up-regulate its own antioxidant defense system. Imbalances between
reactive oxygen specie production and antioxidant systems could have a negative impact
in creating oxidative stress which, in turn, can negatively impact the reproductive
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process. Oxidative stress is increased during pregnancy, and is directly related to several
pregnancy disorders, such as spontaneous abortions, embryopathies, preeclampsia, fetal
growth restriction, preterm labor, and low birth weight (Kaïs et al. 2010). The links
between oxidative stress, the female reproductive system and the development of
negative pregnancy outcomes, results in important concerns in both human and animal
reproductive sciences (Kaïs et al. 2010).
Compromised pregnancies experiencing fetal growth restriction have been
accompanied by increased oxidative damage. These pathways could be related to nitric
oxide, a powerful vasodilator that helps modulate blood flow during pregnancy
(Beckman & Koppenol 1996). Free radicals, such as superoxide anion react with nitric
oxide and decrease its bioavailability, which can lead to a decrease in blood flow.
Melatonin has a part in the regulation of blood pressure, myocardial contractility, and
arterial vasoconstriction and vasodilation (Paulis & Simko 2007; Lemley et al. 2012).
Melatonin has been known to decrease peripheral resistance but when analyzing isolated
arteries, this finding becomes increasingly controversial, as this cascade cannot
completely be explained (Paulis & Simko 2007). It is a possibility that melatonin may
play a pivotal role in peripheral vascular resistance through melatonin receptors (Lemley
et al. 2013). Receptor-mediated vasoconstriction on the vascular system could be
counter-balanced by receptor-mediated nitric oxide release, which could further enhance
melatonin’s antioxidant properties (Paulis & Simko 2007).
Many studies have been conducted involving nutrient restriction during
pregnancy; however, few studies addressed uteroplacental hemodynamics of improved
fetal growth (Lemley et al. 2012). In addition, supplementing dietary melatonin may have
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the ability of altering fetal organ development and functional capacity (Lemley et al.
2012). Dietary melatonin increases total umbilical artery blood flow, as well as increases
the cross sectional area of the umbilical cord in the ewe (Lemley et al. 2012). With
melatonin’s strong antioxidant capacity, melatonin can stimulate peroxidase activity and
scavenge peroxyl radicals generated during lipid peroxidation (Reiter et al. 2007).
Serving as an antioxidant, melatonin can reduce oxidative stress and partially negate the
decreased birth weight in nutrient restricted rats (Richter et al. 2009). Moreover,
melatonin supplementation increased placental antioxidant enzyme activity in midgestating ewes (Lemley et al. 2013). Our primary objective was to measure uterine artery
hemodynamics during late gestation following melatonin supplementation in Holstein
heifers. Therefore, we hypothesized that dietary melatonin supplementation would
increase uterine artery hemodynamics and total antioxidant capacity in late gestating
Holstein heifers.
Materials and Methods
Animal care and use were according to protocols approved by the Mississippi
State University Institutional Animal Care and Use Committee.
Animal Model
Dairy heifers were artificially inseminated with sex-sorted semen at the Joe
Bearden Dairy Research Center. Artificial insemination dates ranged from December 6,
2012 to January 30, 2013. Twenty singleton pregnant Holstein heifers were selected at
day 70 to 90 of pregnancy. The project consisted of a randomized complete block design.
The heifers were blocked by both artificial insemination date and body weight. On day
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170 of gestation, the heifers were trained to the Calan feeding system (American Calan,
Northwood, NH, USA) to monitor dry matter intake. Dietary melatonin supplementation
(MEL; n = 10) or no melatonin supplementation (CON; n = 10) started on day 190 of
gestation and ended on day 262. Melatonin (Batch 130307, Health Supplement
Wholesalers, Red Lion, PA, USA) supplementation was individually provided by topdressing grain with 2 mL of 10 mg/mL melatonin dissolved in ethanol (20 mg of
melatonin per head per day). The melatonin dosage was based on previous dietary
melatonin supplementation studies with cattle (Zinn et al. 1988; Sanchez-Barcelo et al.
1991; Dahl et al. 2000). A total mixed ration (Table 1) of 8.9 kg/d was provided based on
NRC recommendations for a pregnant Holstein heifer during late gestation along with ad
libitum access to water. The total mixed ration was analyzed for dry matter, ash, crude
protein, neutral detergent fiber, and acid detergent fiber. Maternal body weights were
recorded every 14 days. Maternal body condition was scored on a 1 to 5 scale, with 1 =
emaciated and 5 = obese, by two separate evaluators on days 178 and 256 (± 2.5 days;
SE) of gestation. Milk yield was recorded for the first 30 days of lactation. Blood samples
were collected via venipuncture of the coccygeal vessels on days 180 (baseline), 210,
240, and 262 of gestation. Maternal heart rate (HR) and blood pressure (BP) were
collected prior to blood sampling using a digital sphygmomanometer (Omron,
Schaumburg, IL, USA). Mean arterial pressure (MAP) was calculated by taking one third
of the distance between the systolic pressure and the diastolic pressure. In addition, pulse
pressure was calculated by subtracting the diastolic pressure from the systolic pressure.
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Color Doppler Ultrasonography
Uterine artery hemodynamics, contralateral and ipsilateral to the conceptus, were
determined on days 180 (baseline), 210, 240, and 262 of gestation via color Doppler
ultrasonography (MicroMaxx, SonoSite, Inc., Bothell, WA, USA) using a transrectal
probe (Sonosite MicroMaxx with a Linear Endorectal L52x probe). Following techniques
described by Camacho et al. (2014), briefly the uterine artery was identified by following
the abdominal aorta towards the origin of the external iliac artery. The internal iliac artery
was located by moving the probe caudally. The left and right uterine arteries where
identified as a major branch of the iliac arteries. Moreover, the uterine arteries were
palpated to assure pliability and pulsatility, which is easily observed during late gestation.
The ultrasound transducer was aligned to the uterine artery at an average angle of
insonation of 56 ± 2 degrees (mean ± SE). Three cardiac cycle waveforms from two
independent ultrasound scans were used to calculate systolic velocity (s; cm/s), diastolic
velocity (d; cm/s), s:d ratio, pulsatility index (PI), and resistance index (RI) using preset
functions on the Doppler ultrasound. Mean velocity (MnV) was calculated using the
equation: (s – d)/PI. Blood flow was calculated using the equation: (MnV*vessel
area*60s).
Blood Sampling Analysis
A subsample of heifers (n = 5 per treatment) were selected to measure serum
melatonin concentrations in peripheral circulation pre-feeding and 1 hour post feeding at
day 216 ± 2 (mean ± SE) of gestation. Melatonin concentrations were determined with an
ELISA kit (MyBiosource, San Diego, CA, USA). The melatonin ELISA assay was
performed following manufacturer’s instructions. Briefly, samples were analyzed against
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a melatonin standard curve (0 – 1,000 pg/mL), with a sensitivity of 1.0 pg/mL and a spike
recovery of 95%. The intra-assay coefficient of variation for the melatonin assay was
8.3%.
Total antioxidant capacity was determined with a colorimetric assay kit (Cayman
Chemical Co., Ann Arbor, MI, USA). The antioxidant capacity assay was performed
following manufacture’s instructions except the serum was diluted with assay buffer to
place unknowns within the range of the standard curve. Antioxidant capacity of serum
was determined based on the inhibition of ABTS (2,2’-Azino-di-[3-ethylbenzthiazoline
sulphonate]) oxidation by metmyoglobin. The ABTS oxidation product was monitored at
405 nm via a Spectra Max Plus plate reader (Sunnyvale, CA, USA). The kit does not
separate aqueous- and lipid-soluble antioxidants; therefore, the combined antioxidant
activities of all constituents in maternal serum are reported. The capacity of serum
antioxidants in unknown samples to prevent substrate oxidation is compared with that of
a tocopherol analogue (Trolox) and is reported as mM Trolox equivalents. Samples were
analyzed against a linear Trolox standard curve (0 – 0.33 mM), with a sensitivity of 0.01
mM and intra- and interassay coefficients of variation of 14.4% and 9.6%, respectively.
Total serum nitrites were determined using the QuantiChrom Nitric Oxide Assay
Kit (BioAssay Systems, Inc. Haward, CA, USA) following the methods of Lemley et al.
(2013). Briefly, samples were deproteinized and quantified following the reduction of
total nitrates to nitrites using the Griess method and analyzed against a linear nitrites
standard curve (0 – 100 μM), with a sensitivity of 0.6 μM and intra- and interassay
coefficients of variation of 3.3% and 1.3%, respectively.
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Serum progesterone and estradiol were determined using RIA kits (Siemens
Healthcare Diagnostics Inc, Los Angeles, CA, USA) following the methods of Hart et al.
(2014). For both assays the log concentration of the standard (progesterone or estradiol)
was plotted against the logit of percent bound. The intra-assay coefficient of variation for
the progesterone RIA was 2.6%. The intra-assay coefficient of variation for the estradiol
RIA was 4.15%.
Statistical Analysis
Dependent variables measured over time were analyzed using repeated-measures
ANOVA of the MIXED procedure of SAS (SAS software version 9.3, SAS Institute,
Cary, NC, USA), and means were separated using the PDIFF option of the LSMEANS
statement. The model statement contained dietary treatment, gestational day, and their
respective interaction. Main effects of dietary treatment or gestational day are discussed
in the absence of significant (P < 0.05) treatment by day interactions. Least square means
and SEM are reported. Statistical significance was declared at P < 0.05.
Results
Maternal Body Condition
Heifer body weight increased (P < 0.01) as gestational day increased (Fig. 3);
however, melatonin treatment did not influence (P = 0.34) heifer body weight. Average
daily gain from day 180 to 262 of gestation was similar (P = 0.64) between MEL (0.92 ±
0.05 kg/d) versus CON (0.87 ± 0.07 kg/d). Body condition score was not different (P =
0.61) between heifers receiving MEL and CON and averaged 3.45 ± 0.08. Dry matter
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intake throughout the supplementation period was not different (P = 0.14) between
dietary treatment groups and averaged 8.95 ± 0.03 kg/day.
Uterine Artery Hemodynamics
Main effects of gestational day (P < 0.01) and MEL treatment (P = 0.01) were
observed for ipsilateral uterine artery blood flow (Fig. 4A). On average ipsilateral uterine
artery blood flow was increased by 32% in MEL treated heifers compared to CON. A
main effect of gestational day (P = 0.02) was observed for ipsilateral RI, which decreased
at days 210, 240, and 262 versus 180 (Fig. 4B). A main effect of gestational day (P <
0.01) was also observed for ipsilateral PI, which was decreased at days 210, 240, and 262
of gestation versus 180 (Fig. 4C). Ipsilateral RI (P = 0.19) and PI (P = 0.29) were not
influenced by melatonin supplementation. A main effect of gestational day (P < 0.01)
was observed for ipsilateral diameter of the uterine artery, which increased from day 180
to 240 of gestation. Ipsilateral diameter of the uterine artery was not influenced (P = 0.46)
by melatonin supplementation. Both MnV and s:d ratio on the ipsilateral side were not
different (P ≥ 0.11) across gestational day or melatonin treatment (data not shown).
A main effect of gestational day (P < 0.01) was observed for contralateral uterine
artery blood flow, which increased from d 180 to d 240 (Fig. 5A). Contralateral uterine
artery RI (Fig. 5B) and PI (Fig. 5C) were not different across gestational day (P > 0.09)
or dietary treatment (P > 0.28). Contralateral uterine artery MnV and s:d ratio were not
different (P ≥ 0.16) across gestational day or dietary treatment (data not shown). A main
effect of gestational day (P < 0.01) was observed for contralateral diameter of the uterine
artery, which increased as gestation proceeded. Dietary treatment did not influence (P =
0.87) contralateral diameter of the uterine artery.
28

A main effect of gestational day and melatonin treatment was observed for total
uterine artery blood flow (Fig. 6). Total uterine blood flow was increased (P < 0.01) by
25% in the MEL treated heifers compared to the CON. There were no differences across
gestational day (P = 0.81) or dietary treatment (P = 0.52) for maternal mean arterial
pressure (Fig. 7A). A dietary treatment by gestational day interaction (P = 0.02) was
observed for pulse pressure (Fig. 7B), which was increased in MEL-treated heifers vs.
CON at day 240 of gestation. There was an increase (P < 0.01) in heart rate as gestation
proceeded. In addition, MEL-treated heifers had a 9% increase in heart rate when
compared to the CON-treated heifers (P = 0.03) (Fig. 7C).
Maternal Serum Analysis
Melatonin concentrations showed a dietary treatment by hour interaction (P <
0.01). At hour 0 there was no difference between the MEL treated heifers vs. CON
treated heifers; however, at hour 1 post-supplementation there was an 8-fold increase in
serum concentrations of melatonin in the MEL-treated heifers when compared to the
CON-treated heifers (Fig. 8).
A main effect of gestational day (P < 0.01) was observed for maternal
concentrations of estradiol-17β (Fig. 9A). There was no main effect of dietary treatment
(P = 0.06) observed for maternal concentrations of estradiol-17β. Estradiol-17β increased
with increasing gestational age with the exception of no difference from day 180 to 210.
In addition, estradiol-17β was not different in MEL-treated heifers vs. CON treated
heifers. A main effect of gestational day (P < 0.01) and dietary treatment (P = 0.02) were
also observed for concentrations of progesterone (Fig. 9B). Progesterone was increased
from day 180 to 210 followed by no difference from day 210 to 240 and ending with a
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decrease in concentrations of progesterone from day 240 to day 262. There was also a
decrease in progesterone concentrations in MEL-treated heifers vs. CON-treated heifers.
Main effects of gestational day (P < 0.01) and dietary treatment (P < 0.01) were
observed for total serum antioxidant capacity (Fig. 10A). Total serum antioxidant
capacity was increased on days 210, 240, and 262 of gestation compared to day 180.
There was also a main effect of dietary treatment (P < 0.01) when examining total serum
antioxidant capacity, which was increased by 39% in MEL-treated heifers when
compared to CON. Maternal concentrations of total serum nitrites increased (P < 0.01) as
gestation proceeded (Fig. 10B). There was no main effect of dietary treatment (P = 0.83)
when examining total serum nitrites.
Parturition and Lactation
Duration of gestation was not different (P > 0.50) between treatments and
averaged 275 ± 2 days. Birth weight (P = 0.63) was not different between treatments and
averaged 35 ± 2 kg. A treatment by day interaction (P < 0.01) was observed for milk
yield (Fig. 11), whereby milk yield was increased by 41% and 33% on days 2 and 3 of
lactation in MEL vs. CON heifers, respectively.
Discussion
In the present study, ipsilateral uterine artery blood flow, total uterine artery blood
flow, and total antioxidant capacity were increased in pregnant heifers supplemented with
dietary melatonin. In addition, no main effects or interactions of melatonin
supplementation were observed for heifer body weight, daily feed intake, contralateral
blood flow, or gestational length. Melatonin has vasodilation capabilities and could have
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the potential of increasing blood flow and antioxidant capacity in pregnant heifers.
Additional studies addressing uteroplacental hemodynamics in models of improved fetal
growth are critical as this research is novel.
A limited number of studies have utilized Doppler ultrasonography to examine
reproductive tract blood flow measurements in cattle. One of the first studies examining
uterine artery hemodynamics with Doppler ultrasonography included two Simmental
cows and one Brown Swiss cow that were both uniparous and nonlactating (Bollwein et
al. 2001). Uterine artery resistance index (RI) values located ipsilateral to the pregnant
uterine horn were decreased with the exception of months 1 and 8 (Bollwein et al. 2001).
Resistance index has been negatively correlated with time averaged maximum velocity
(TAMV) of blood flow and the diameter (d) of the uterine artery (Bollwein et al. 2001).
At 7 months of gestation, ipsilateral uterine artery blood flow was approximately 5
L/min, while contralateral uterine artery blood flow was approximately 1.5 L/min
(Bollwein et al. 2001). Using surgically implanted electromagnetic flow probes, Ferrell
and Ford (1980) observed approximately 3.7 L/min at 7 months of gestation. Reynolds
and Ferrell (1987) using the steady-state diffusion method (injection of radioactive
substances) observed approximately 7 L/min at 7 months of gestation. The current study
observed approximately 5 L/min in the ipsilateral horn with the heifers that were treated
with melatonin compared to the controls having approximately 3 L/min at 7 months of
gestation. In conclusion, various techniques can be performed in order to calculate blood
flow and the observations from the current study are closely related to these previous
reports.
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When analyzing blood flow in sheep, on day 90 of gestation melatonin-infused
dams had an increase in umbilical artery blood flow as well as fetal descending aorta
blood flow (Lemley et al. 2013). At day 90 of gestation, umbilical artery blood flow and
umbilical artery blood flow relative to placental weight was increased in the melatonin
treated dams (Lemley et al. 2013). Therefore, dams supplemented with melatonin
typically have increased feto-placental blood flow, and as a result can lead to increased
placental efficiency. When analyzing blood flow, heart rate is also a common variable of
interest as these measurements can be directly related to cardiac output. According to
previous research, fetal heart rate was not different in ewes treated with melatonin
(Lemley et al. 2013); however it is important to note that in the present study, maternal
heart rate was increased by approximately 9% in heifers supplemented with dietary
melatonin.
The increase in blood flow in melatonin-supplemented sheep may be partially
mediated via melatonergic receptor-specific pathways (Lemley et al. 2013). Melatonin
supplementation has also been associated with improved oxidative status (Paulis &
Simko 2007). Melatonin has the ability to increase vascular relaxation through
antioxidant properties, which could, in turn, increase the scavenging of superoxide free
radicals resulting in increased bioavailability of nitric oxide (Reiter et al. 1995; Jauniaux
et al. 2006). Lemley et al. (2012) showed that dietary melatonin supplementation caused
a 20% increase in umbilical artery blood flow; however there was no change in uterine
artery blood flow. Thakor et al. (2010) imposed a nitric oxide clamp during melatonin
infusion, which then verified that these responses in umbilical blood flow were being
mediated by nitric oxide production and/or bioavailability.
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Melatonin secretion is known to follow a diurnal pattern, with melatonin
concentrations being increased during night-time hours compared to day-time hours.
During pregnancy, these same responses are maintained but peak plasma concentrations
may vary at different stages of pregnancy (Kennaway et al. 1987; Pang et al. 1987). Rat
offspring prior to post-natal day 10 do not have the pineal enzymes to synthesize
melatonin (Reppert & Klein 1978). While these enzymes are absent until day 10,
melatonin still crosses the placenta and can be transferred in maternal milk (McMillen &
Nowak 1988; Reppert et al. 1979; Reppert & Klein, 1978). With these findings, it is
evident to see that the dam serves as a natural source of melatonin for the offspring
during gestation and into early lactation (Jahnke et al. 1999). Lastly, melatonin is known
to mediate maternal-fetal transfer of information related to circadian rhythm and
photoperiod (Williams et al. 1991; Velàzquez et al. 1992).
Feeding exogenous melatonin to female adult rats can cause disruption of normal
estrous cycles and reduced fertility, due to the suppression of luteinizing hormone and
resulting in the suppression of ovulation (Rivest 1987; Vaughan et al. 1976; Ying and
Greep 1973; Walker et al. 1982). Using a rodent model, Jahnke et al. (1999), examined
mammary tissue and serum hormone concentrations of term rats supplemented with
melatonin on days 6 through 19 of gestation. Mammary glandular tissue and serum
hormone concentrations of term pregnant rats analyzing mammary glandular tissue,
serum concentrations of estradiol-17β, progesterone, and luteinizing hormone on day 20
of gestation are not found to be different (Jahnke et al. 1999). In contrast, the present
study found a decrease in progesterone, whereas estradiol-17β concentration tended to
decrease in those that were supplemented with melatonin verses the CON. The variation
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between the two studies could be due to specie differences or the dosage of melatonin
provided. Sprague-Dawley-derived rats that were exposed to 0, 50, 100, or 200 mg/kg of
BW/d of melatonin on gestation days 6 through 19 showed no difference in gravid uterine
weight (Jahnke et al. 1999). Although the current study did not determine gravid uterine
weight, it did measure blood flow, which is highly correlated with placental efficiency
(Lemley et al. 2013).
Additional studies were performed in mice (Sanchez-Barcelo et al. 1990; San
Martín et al. 1995) and red deer (Asher et al. 1994) showing that melatonin inhibits
mammary gland development in vivo and in vitro; therefore, suggesting a direct
inhibition of growth during lobuloaveolar development (Sanchez-Barcelo et al. 1990; San
Martín et al. 1995). In order for lobuloalveolization to develop, an increase in serum
concentrations of estrogen, progesterone, prolactin, and glucocorticoids must occur
(Dembinski & Shiu 1987; Ichinose & Nandi 1966; Vonderhaar 1987). Prolactin is known
to be a mediator in mammary gland growth (Asher et al. 1994). It is important to note
that these observations were seen in mice and deer rather than dairy animals that were
used in the current study. The mouse strain used in the experiments previously mentioned
was lacking the enzymes necessary for melatonin synthesis (Ebihara et al. 1986; Ebihara
et al. 1987). It is possible that since these mice do not carry the ability to make
endogenous melatonin, perhaps the mammary growth tissue did not respond in the same
fashion as cattle.
A study performed by Dahl et al. (2000) tested the hypothesis that dietary
melatonin supplementation in cattle mimicking a short-day pattern of release would
decrease milk yield during an established lactation. The cows were exposed to 18 h of
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light and 6 h of darkness. Melatonin-supplemented cows were treated with melatonin in
the middle of the photophase for 8 weeks and found no difference in milk yield between
treatment groups (Dahl et al. 2000). The experiment was then repeated during early
lactation, but the same results were found with no effect on milk yield (Dahl et al. 2000).
In contrast, the current study showed an increase in milk yield on days 2 and 3. The
differences in responses could have been due to Dahl et al. (2000) using mature cows and
the current study using heifers. The Dahl et al. (2000) study also supplemented melatonin
by a daily oral bolus, whereas the current study top-dressed grain with melatonin. This
difference in supplementation could result in a different rate of melatonin diffusion into
the blood stream. There are a number of factors that regulate mammary gland
development and milk yield that need further research.
There are several implications that melatonin supplementation could have on the
possibility of altering uterine artery hemodynamics through negating the consequences of
fetal growth restriction. Compromised pregnancies have a decrease in uterine blood flow,
which is commonly associated with fetal growth restriction. This study utilized a
technique that can have the potential to negate these compromised pregnancies by
supplementing melatonin and improving uterine artery hemodynamics. Increasing uterine
blood flow during late gestation could be a potential benefit to producers by having the
potential for healthier calves at birth while not affecting gestation length or birth weight.
Increased uterine blood flow has the potential to increase placental transport capacity
supporting fetal growth and metabolism. With the observed increase in total uterine
artery blood blow, there could be future implications of increased growth of offspring by
further investigating blood distribution and physiological functions of various organs.
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The improved antioxidant capacity during melatonin supplementation could be
directly related to the increase in uterine artery blood flow. These antioxidant capabilities
could result in less stress during pregnancy resulting in the possibility of having fewer
compromised pregnancies. With the observed increase in milk yield, this could have a
large impact on the dairy industry. This increase in milk yield can result in more pounds
of milk to sell benefiting both the consumer and the producer. Early lactation is a vital
time point in a calf’s life and if it can be manipulated by melatonin supplementation this
could have an impact on calf survival and overall health. In the future, replication of this
experiment in beef cattle could have the potential of increasing milk availability, which
could result in health benefits following parturition. Future studies using melatonin along
with other therapeutics is of utmost importance in better understanding future
implications.
Table 1

Ingredient and average nutrient composition of diets fed to pregnant heifers

1

Dry cow grain consisted of 21.9% wheat middling, 21% soy hulls, 17% ground corn,
13.5% cottonseed meal, 11.3% soybean meal, 5.21% fishmeal, 4.8% calcium carbonate,
1.35% magnesium oxide, 0.75% salt, 0.71% mono-dical, 0.68% mag-pot, 0.58% 20,000
IU vitamin E, 0.34% selenium, 0.29% zinc-pro, 0.25% fat (grease). Dry cow grain was
calculated not analyzed.
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Figure 3

Maternal body weights in heifers treated with (MEL) or without dietary
melatonin (CON) from day 190 to 262 of gestation

A main effect of gestational day was observed (P < 0.01), while melatonin treatment did
not influence body weight (P = 0.34).
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Figure 4

Ipsilateral uterine artery blood flow RI and PI in heifers treated with (MEL)
or without dietary melatonin (CON) from day 190 to 262 of gestation

Main effects of gestational day (P < 0.01) and melatonin treatment (P = 0.01) were
observed for ipsilateral uterine artery blood flow (A). A main effect of gestational day (P
= 0.02) was observed for ipsilateral RI (B). A main effect of gestational day (P < 0.02)
was also observed for ipsilateral PI (C). Ipsilateral RI (P = 0.19) and PI (P = 0.29) were
not influenced by melatonin supplementation.
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Figure 5

Contralateral uterine artery blood flow, RI, and PI in heifers treated with
(MEL) or without dietary melatonin (CON) from day 190 to 262 of
gestation

A main effect of gestational day (P < 0.01) was observed for contralateral uterine artery
blood flow, with blood flow increasing from d 180 to d 240 (A). Contralateral uterine
artery RI (B) and PI (C) were not different across gestational day (P = 0.10; P > 0.09) or
dietary treatment (P = 0.43; P = 0.28), respectively.
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Figure 6

Total uterine artery blood flow in heifers treated with (MEL) or without
dietary melatonin (CON) from day 190 to 262 of gestation

Main effects of gestational day (P < 0.01) and melatonin treatment (P < 0.09) were
observed for total uterine blood flow.
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Figure 7

Maternal mean arterial pressure, pulse pressure, and heart rate in heifers
treated with (MEL) or without dietary melatonin (CON) from day 190 to
262 of gestation

There were no differences across gestational day (P = 0.81) or dietary treatment (P =
0.52) for maternal mean arterial pressure. A treatment by gestational day interaction (P =
0.02) was observed for pulse pressure (B). Asterisk (*) at day 240 representing the
increase in MEL versus CON at day 240 of gestation. A main effect of gestational day (P
< 0.01) and dietary treatment (P = 0.03) was observed for maternal heart rate (C).
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Figure 8

Maternal serum melatonin concentrations treated with (MEL) or without
dietary melatonin (CON) in heifers at hour 0 (pre-melatonin
supplementation) and hour 1 (post-melatonin supplementation)

A dietary treatment by hour interaction (P < 0.04) was observed. Different letters
represent a significant difference (P < 0.05).
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Figure 9

Maternal serum concentrations of estradiol-17β and progesterone in heifers
treated with (MEL) or without dietary melatonin (CON) from day 190 to
262 of gestation

A main effect of gestational day (P < 0.01) was observed for maternal concentrations of
estradiol-17β (A). A main effect of gestational day (P < 0.01) and melatonin
supplementation (P < 0.05) was observed for concentrations of progesterone (B).
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Figure 10

Maternal total antioxidant capacity and total nitrites in heifers treated with
(MEL) or without dietary melatonin (CON) from day 190 to 262 of
gestation

Main effects of gestational day (P < 0.02) and dietary treatment (P < 0.01) were observed
for total serum antioxidant capacity (A). A day effect (P < 0.01) was observed for total
serum nitrites increasing with gestational age (B).
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Figure 11

Maternal milk yield through day 30 of lactation in heifers treated with
(MEL) or without melatonin (CON) from day 190 to 262 of gestation

A treatment by day interaction (P < 0.01) was observed for milk yield. Asterisk (*)
represents a significant difference (P < 0.05) between treatments within a day.
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EFFECTS OF SUPPLEMENTING DIETARY MELATONIN DURING LATE
GESTATION ON GROWTH AND CARDIOVASCULAR
MEASUREMENTS OF OFFSPRING

Introduction
Fetal growth and development are complex biological events that can be
influenced by genetic, epigenetic, maternal maturity, environment, and other factors
(Redmer et al. 2004; Gootwine 2005). Fetal growth restriction can occur as the result of
an insult to one of the previous variables mentioned. When fetal growth restriction
occurs, the result can be permanent stunting of post-natal growth, decrease in feed
efficiency, negative effects on whole body composition and meat quality, as well as longterm health effects and athletic performance (Wu et al. 2006). When endocrine or
nutritional status is altered, developmental adaptions may occur that permanently change
the structure, physiology, metabolism, and post-natal growth of the offspring (Wu et al.
2006).
Undernutrition or overnutrition can also play critical roles in intrauterine growth
restriction. From this research, a field of study called fetal programming has been derived
in an effort to further investigate intrauterine growth restriction via programming the
fetus during gestation. Fetal programming is when the intrauterine environment of the
conceptus may alter expression of the fetal genome and have lifelong consequences (Wu
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et al. 2006). Recently, our laboratory began investigating potential therapeutics to
stimulate offspring growth and development during late gestation (Lemley et al. 2012).
For example, melatonin supplementation during a compromised or normal pregnancy
may alter uteroplacental blood flow via melatonergic receptor-mediated pathways or
indirectly by decreasing oxidative stress in the vascular system (Lemley et al. 2012;
Brockus et al. 2015).
Melatonin is unique in that it has the ability to protect the body against free
radicals via direct or indirect pathways (Reiter et al. 1995). Oxidative stress is increased
during pregnancy and is directly related to several pregnancy disorders, such as
spontaneous abortions, embryopathies, preeclampsia, fetal growth restriction, preterm
labor, and low birth weight (Kaïs et al. 2010). The links between oxidative stress, the
female reproductive system, and the development of negative pregnancy outcomes,
results in important concerns in both human and animal reproductive sciences (Kaïs et al.
2010).
Close relationships between melatonin and the cardiovascular system exist
(Sewerynek 2002). Moreover, melatonin supplementation increased distal skin
temperature and decreased core body temperature (Kräuchi et al. 1997) as well as
initiated primary hair follicle growth (Nixon et al. 1993). With these findings, the current
study measured offspring blood pressure, heart rate, liver blood flow, skin temperature,
and hair growth to analyze if supplementing melatonin to the dams would have an effect
on these variables during post-natal development. Previously, our lab showed that
supplementing melatonin increased uterine artery blood flow (Brockus et al. 2015);
therefore, we were interested to see if this finding would be programmed in the offspring.
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Based off of previous fetal programming studies and melatonin’s antioxidant
effects, the current study supplemented dietary melatonin to dams and followed postnatal growth and cardiovascular measurements of their offspring. Our primary objective
was to measure hepatic portal blood flow and growth following melatonin
supplementation in Holstein heifers during late gestation. Therefore, we hypothesized
that supplementing dietary melatonin to the dams would increase post-natal growth and
cardiovascular measurements.
Materials and Methods
Animal care and use were according to protocols approved by the Mississippi
State University Institutional Animal Care and Use Committee.
Animal Model
The establishment of pregnancy and maternal treatments were previously outlined
in Brockus et al. (2015). Briefly, heifers were inseminated to sex-sorted semen between
December 6, 2012 and January 30, 2013. On day 170 of gestation, the heifers were
trained to the Calan feeding system to monitor individual dry matter intake. Dietary
melatonin supplementation (MEL; n =10) or no melatonin supplementation (CON; n
=10) started on day 190 of gestation and ended on day 262. Melatonin (Batch 130307,
Health Supplement Wholesalers, Red Lion, PA, USA) supplementation was provided by
top-dressing grain with 2 mL of 10 mg/mL melatonin dissolved in ethanol (20 mg of
melatonin per head per day). A total mixed ration of 8.9 kg/d was provided based on
NRC recommendations for a pregnant Holstein heifer during late gestation along with ad
libitum access to water. Maternal endocrine and uterine hemodynamic measurements
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were collected during melatonin supplementation and were previously reported (Brockus
et al. 2015).
At birth, calves were separated from their dams and given 3.8 L of colostrum.
Calves were managed identically with no further treatments. Calves were fed 5.7 L of
whole milk daily and offered 0.9 kg/d of starter grain. Starter grain was increased by 0.9
kg/d when orts were 0 kg. Two calves were aborted during the fall calving, one from a
melatonin treated dam and one from a control treated dam. Therefore, measurements
were recorded on (n = 9) calves born to melatonin treated dams (7 heifer calves; 2 bull
calves) and (n = 9) calves born to control dams (8 heifer calves; 1 bull calf). Calf (n = 18)
body weight and heart girth were collected weekly from weeks 0 through 9. Curved
crown rump length, abdominal circumference, hip height, wither height, blood pressure
using a digital sphygmomanometer (Omron, Schaumburg, IL, USA), heart rate, and a
blood sample were collected on weeks 0, 1, 2, 3, and 4 of age.
Thermal imaging using a Flir ThermaCAM® S60 (Flir Systems, Boston, MA,
USA) infrared thermography camera and hair weight were collected on week 1. Firstly, a
hair sample was collected in a pre-weighed bag by shaving a 5.08 x 10.16 cm area on the
animals’ right thoracic region directly behind the shoulder. The hair plus the pre-weighed
bag was then weighed again to calculate hair weight. The hair weight was then subtracted
from the pre-weighed bag weight to find the actual hair weight. Next, images were taken
of the 5.08 x 10.16 cm shaved area and adjacent unshaved area (Fig. 12). Temperatures
for both the shaved and unshaved areas were then analyzed using ThermaCAM
Researcher Pro 2.7 software (FLIR Systems). Ambient temperature (P = 0.76) and
humidity (P = 0.36) were not different at the time of thermal imaging between calves
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born to MEL-treated dams versus CON-treated dam. Average temperature of the shaved
area was determined by constructing a rectangular polygon corresponding to the spot and
analyzing temperatures with this area. The exact polygon was transferred to the unshaved
area and an average surface temperature was calculated for the unshaved area. The same
polygon was used to ensure a standard surface area was being measured.
Doppler Ultrasonography
Hepatic portal blood flow was determined on weeks 0 and 4 of age via Doppler
ultrasonography (MicroMaxx, SonoSite, Inc., Bothell, WA, USA) using a transabdominal
probe (Sonosite MicroMaxx with a Phased array P17 1-5MHz 17x17mm probe; Fig. 13).
The liver was first identified on the right side of the calf. The hepatic portal vein transfers
blood from the gastrointestinal tract to the liver. The superior mesenteric vein and the
splenic vein form the portal vein. The portal vein was located by scanning through the
liver at the 10th intercostal space. The ultrasound transducer was aligned to the portal vein
at an average angle of insonation of 66 ± 9 degrees. Mean velocity (MnV) was calculated
using the equation: (systolic velocity – diastolic velocity)/pulsatility index. Blood flow
was calculated using the equation: (MnV*vessel area*60 sec).
Blood Sampling Analysis
Blood serum was collected on weeks 0, 1, 2, 3, and 4 of age and analyzed for total
antioxidant capacity, nitrites, and cortisol concentrations. Insulin-like growth factor one
(IGF-1) was analyzed from blood serum on weeks 0 and 4.
Total antioxidant capacity was determined with a colorimetric assay kit (Cayman
Chemical Co. Ann Abor, MI, USA). The antioxidant capacity assay was performed
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following manufactures’ instructions except that the serum was diluted with assay buffer
to place unknowns within the range of the standard curve. Antioxidant capacity of serum
was determined based on the inhibition of ABTS (2,2’-Azino-di-[3-ethylbenzthiazoline
sulphonate]) oxidation by metmyoglobin. All serum samples were diluted in a 1:4
dilution. The ABTS oxidation product was monitored at 750 nm via a Spectra Max Plus
plate reader (Sunnyvale, CA, USA). The kit does not separate aqueous- and lipid-soluble
antioxidants; therefore, the combined antioxidant activities of all constituents in maternal
serum are reported. The capacity of serum antioxidants in unknown samples to prevent
substrate oxidation is compared with that of a tocopherol analogue (Trolox) and is
reported as mM Trolox equivalents. Samples were analyzed against a linear Trolox
standard curve (0 – 0.33 mM), with a sensitivity of 0.01 mM and intra- and interassay
coefficients of variation were 13.3% and 5.9%, respectively.
Total serum nitrites were determined using the QuantiChrom Nitric Oxide Assay
Kit (BioAssay Systems, Inc., Haward, CA, USA) following the methods of Lemley et al.
(2013). Briefly, samples were deproteinized and quantified following the reduction of
total nitrates to nitrites using the Griess method and analyzed against a linear nitrites
standard curve (0 – 100 μM), with a sensitivity of 0.6 μM and intra- and interassay
coefficients of variation of 1.3% and 2.27%, respectively.
Cortisol was determined using the Coat-a-Count cortisol RIA kit (Siemens
Healthcare Diagnostics Inc., Los Angeles, CA, USA). The cortisol assay was performed
following manufacture’s instructions. Briefly, following the addition of calibrators and
samples to their respective tubes, 1mL of 125I cortisol was added and samples incubated
for 45 minutes at 37°C in a water bath. The tubes were then decanted thoroughly and
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analyzed using a Packard gamma counter (Meriden, CT, USA). Intra-assay coefficient of
variation was 4.15%.
Insulin-like growth factor 1 was determined using an ELISA Kit (MybioSource,
Inc., San Diego, CA, USA). The IGF-1 assay was performed following manufacture’s
instructions. Briefly, this assay used the competitive inhibition enzyme immunoassay
technique. Standards or sample was added to the appropriate plate wells with an antibody
specific for IGF-1 and Horseradish Peroxidase (HRP) conjugated IGF-1. The competitive
inhibition reaction is launched between HRP labeled IGF-1 and unlabeled IGF-1 with the
antibody. A substrate solution was then added to the wells and color develops in opposite
to the amount of IGF-1 in the sample. Lastly, optical density was determined using a
Spectra Max Plus plate reader set to 450 nm. Intra-assay coefficient of variation was
10.16%.
Statistical Analysis
Dependent variables were analyzed using repeated measures ANOVA of the
mixed procedure of SAS (SAS software version 9.3, SAS Institute, Cary, NC, USA).
Means were separated using the PDIFF option of the LSMEANS statement. The model
statement contained dietary treatment, age, and their interaction. Main effects of dietary
treatment or age are discussed in the absence of significant treatment by day interactions.
Least square means and SEM are reported. Statistical significance was declared at P <
0.05.

56

Results
Calf Growth Measurements
A treatment by age interaction (P < 0.01) was observed for calf body weight,
which was increased in MEL-treated dams versus CON-treated dams at weeks 8 and 9
(Fig. 14A). A treatment by age interaction (P < 0.01) was also observed for heart girth,
which was decreased in MEL-treated dams versus CON-treated dams at week 2; however
heart girth was increased in MEL-treated dams versus CON-treated dams at week 9 (Fig.
14B). A main effect of age (P < 0.01) was observed for curved crown rump length, which
was increased with age except from weeks 3 to 4 (data not shown). A main effect of age
(P < 0.01) was observed for abdominal circumference, hip height, and wither height,
which were all increased with age (data not shown).
Cardiovascular Measurements
Calf hepatic portal blood flow was not different across age (P = 0.06) and
averaged 2.4 ± 0.4 L/min at week 0 and 3.4 ± 0.5 L/min at week 4 (Fig. 15A). In
addition, calf hepatic portal blood flow was not different between treatments (P = 0.94)
and averaged 2.8 ± 0.5 L/min in the offspring born to MEL-treated dams and 2.9 ± 0.5
L/min in the offspring born to CON-treated dams. Calf hepatic portal blood flow was also
not different by age or treatment when expressed relative to calf body weight (Fig. 15B).
No differences were observed among treatment (P = 0.99) or age (P = 0.50) for mean
velocity. The mean velocity averages were 55.2 ± 6 cm/sec at week 0 and 60.4 ± 6
cm/sec at week 4. Mean velocity among treatments was 58 ± 7 cm/sec in both offspring
born to MEL-treated dams and CON-treated dams. No main effects of treatment (P =
0.22) or age (P = 0.50) were observed for vessel diameter (data not show). The vessel
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diameter averages were 1.2 ± 0.05 cm at week 0 and 1.3 ± 0.05 cm at week 4. Vessel
diameters were 1.2 ± 0.05 cm in offspring born to MEL-treated dams and 1.3 ± 0.05 cm
in offspring born to CON-treated dams.
Pulse pressure was not different across age (P = 0.73) or treatment (P = 0.79)
(Fig. 16A). There was a main effect of age (P = 0.04) when observing mean arterial
pressure, which was increased from week 0 to 1 followed by a decrease from week 1 to 2
and from week 1 to 4 (Fig. 16B). Mean arterial pressure was not different across
treatments (P = 0.19). A main effect of age (P < 0.01) was observed for heart rate with a
decrease from week 1 to 4 (Fig. 16C). Systolic blood pressure was not different across
age (P = 0.15) or treatment (P = 0.28; data not shown). However, there was a main effect
of age for diastolic blood pressure (P = 0.03), which increased from week 0 to 1 followed
by a decrease from week 1 to 2 and week 1 to 4 (data not shown).
Calf Serum Analysis
Insulin-like growth factor 1 was not different between treatments (P = 0.43). A
main effect of age (P = 0.02) was observed for IGF-1 concentrations, which was
decreased from week 0 to 4 (Fig. 15C). An age by treatment interaction (P = 0.04) was
observed for concentrations of cortisol, which was decreased in the MEL-treated dams
compared to the CON-treated dams at week 2 (Fig. 17). Total antioxidant capacity was
not different between treatments (P = 0.14). A main effect of age (P < 0.01) was observed
for total antioxidant capacity, which peaked at week 1 and was lower at all other weeks
(Fig. 18A). Nitrites were not different between treatments (P = 0.69). A main effect of
age (P < 0.01) was observed for nitrites, which peaked at week 1 and was lower at all
other weeks (Fig. 18B).
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Thermal Imaging and Hair Sampling
There were no treatment differences (P = 0.71) in hair weight or adjusted weight
of the hair (P = 0.53). Average temperature of the unshaved skin was not different
between treatments (P = 0.59). Averaged shaved skin temperature was not different
between treatments (P = 0.11).
Discussion
In the present study, there was no difference in calf weight at birth. This finding is
unexpected as we previously reported a 25% increase in total uterine artery blood flow in
MEL-treated dams vs. CON-treated dams (Brockus et al. 2015). Considering that 75% of
the growth of the ruminant fetus occurs during the last two months of gestation
(Robinson et al. 1977), the increase observed in uterine blood flow would be expected to
increase birth weights.
Maternal melatonin supplementation ended at day 262 of gestation. Following
this period all dams and calves were treated identically to examine in utero
developmental programming. Interestingly, offspring born to MEL treated dams showed
an increase in body weight at weeks 8 and 9 of age compared to calves born to CON
treated dams. This increase in body weight could be a melatonin-programmed response
that could possibly change skeletal muscle development and increase weight gain. If this
is indeed a fetal programming response, this is an important find as there is no net
increase in the number of muscle fibers following birth (Glore & Layman 1993;
Greenwood et al. 2000; Nissen et al. 2003).
The increase in body weight of the offspring born to the MEL treated dams could
also be due to the increase in blood flow in utero even though there was not a difference
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in birth weights. The increase in blood flow could have impacted organ development and
therefore caused an increase in feed intake or feed efficiency of the offspring born to
MEL-treated dams.
Melatonin has been well documented as a hormone that has the ability to alter
cardiovascular function (Sewerynek 2002; Paulis & Simko 2007). The current study
examined post-natal alterations in cardiovascular function following melatonin
supplementation in utero. Lemley et al. (2013) showed an increase in fetal aorta blood
flow following maternal melatonin supplementation. Interestingly, the current study
observed no differences in hepatic portal blood flow between offspring born to MELsupplemented vs. CON dams. The presence of vascular melatonin receptors/binding sites
have been demonstrated and linked with vasoconstriction or vasodilatory effects
(Sewerynek 2002). We hypothesized that melatonin receptors could be altered, in utero,
causing the offspring to also show an increase in organ blood perfusion, such as the
hepatic portal blood flow. However, it does not appear that this melatonin mediated
modulation in the cardiovascular system carried over into the offspring for hepatic portal
blood flow.
Impaired melatonin production has been intimately linked to hypertension (Paulis
& Simko 2007). This could be related to the extraordinary antioxidant activity that
melatonin possesses. However, the exact mechanism leading to blood pressure
modulation following melatonin exposure is unknown (Paulis & Simko 2007). In
humans, those with hypertension normally have decreased melatonin secretion
(Sewerynek 2002). Humans administered as little as 1 mg of melatonin had reduced
blood pressure after 90 minutes (Sewerynek 2002). In contrast, the current study
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observed no treatment differences in offspring blood pressure. In our previous work
(Brockus et al. 2015), maternal melatonin supplementation during late gestation did not
alter mean arterial pressure. These findings were unforeseen as a number of studies show
that melatonin decreases blood pressure. This could be a result of the dosage that was
given to the dams not being enough to observe alterations in maternal and offspring blood
pressure. Since heart rate is a function of cardiac output, the differences that were not
seen in hepatic portal blood flow do match up with no differences observed in heart rate.
Melatonin’s effects on body temperature and hair growth are important in this
study as we observed the temperature of both the calf’s skin as it was shaven or
unshaven. Studies in humans observe that following oral administration of melatonin, an
increase in distal skin temperature, decrease in core body temperature, heart rate, and
proximal temperature were observed (Kräuchi et al. 1997; Cagnacci et al. 1995).
However, the temperatures of shaved and unshaved skin were not different between
offspring born to MEL-treated dams vs. CON-treated dams. This difference in responses
could be due to the specie variation in humans versus dairy cattle. Cashmere wethers
received a subcutaneous injection of 70 mg of melatonin in a controlled drug release
formation to see if initiation of fiber growth in hair follicles was influenced by melatonin
(Nixon et al. 1993). Histological examinations of skin biopsies were taken over 14 days
(Nixon et al. 1993). It was found that primary hair follicles of goats supplemented with
melatonin had initiated fiber growth, whereas primary follicles of untreated goats largely
remained in the quiescent stage (Nixon et al. 1993). It was also observed in many
mammals that fiber growth initiation is cued by photoperiod or concentrations of
melatonin (Allain et al. 1981). In contrast to these studies, the current study observed no
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treatment differences in hair weight. This could once again be due to specie differences;
however, it is important to note that the dosage given to the melatonin-treated dams were
at the physiological level whereas the goats were treated with supraphysiological
dosages.
Melatonin has been investigated as being a great modulator for cortisol and stress.
Cortisol was of importance to measure in this study as a decrease in stress could result in
an increase in blood flow to vital organs such as the liver. A study by Guesdon et al.
(2013) using adult ewes characterized stress responses during the day when melatonin is
decreased and at night when melatonin is increased. They found less cortisol during the
night as compared to the day (Guesdon et al. 2013). In order to further isolate if this
response was due to melatonin or darkness, they submitted ewes to familiar conspecific
withdrawal during the night with the lights on (Guesdon et al. 2013). They found that
ewes infused with melatonin showed decreased plasma cortisol as compared to ewes that
were infused with saline (Guesdon et al. 2013). This would support that melatonin has a
calming effect in stressful situations. Similarly, we found a decrease in plasma cortisol at
week 2 in the offspring of the dams who were supplemented with MEL vs. CON. Future
investigations with more intensive blood sampling for cortisol will need to be
accomplished to further verify this response.
Insulin-like growth factor 1 was measured in the current study as it is secreted
from the liver and could be correlated with alterations in blood flow through the liver. A
study by Auldist et al. (2006) used a slow-release melatonin implant in dairy cows to
determine whether administration of melatonin would alter the yield and composition of
milk in the summer. This study also looked at concentrations of IGF-1 twice before
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treatment and three times during the treatment (Auldist et al. 2006). The melatonintreated cows had no difference in IGF-1 concentrations (Auldist et al. 2006). Dahl et al.
(2000) put forth the theory that increases in milk yield observed when photoperiod was
increased might be mediated by IGF-1. Dahl et al. (1997) showed that feeding melatonin
resulted in decreased concentrations of IGF-1. Previous studies in our lab showed that
feeding melatonin increased milk yield on days 2 and 3 of lactation (Brockus et al. 2015).
Similarly to the Auldist et al. (2006) study, the current study observed no differences in
concentrations of IGF-1 in offspring born to MEL-treated dams versus CON-treated
dams. Concentrations of IGF-1 were more intensively analyzed in the Auldist et al.
(2006) study, and this could be a reason as to why the differences in observations were
found.
There are several implications that dietary melatonin supplementation to the dams
could have on the possibility of altering growth and development of the offspring. With
the increase in total uterine artery blood flow of melatonin-treated dams, there could be
future implications of increased growth in the offspring by further investigating blood
distribution and physiological functions of various organs. If melatonin did have the
capability of having these fetal programming consequences, then this could alter organ
function, which could then lead to alterations in animal productivity or longevity. In
order for future implications of fetal programming in the offspring to be observed,
additional research will need to be further investigated.
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Figure 12

Non-thermal image with shaven area (A) and thermal image with shaven
area (B)

Images of a 5.08 x 10.16 cm shaven area on the animals’ right thoracic region directly behind the shoulder.
Thermal colors across image represent various degrees of temperature on calf skin (B). Colors correspond
to bar on right of image which are represented in degrees Fahrenheit.

Figure 13

Hepatic portal vein image in Color Doppler ultrasonography (A) and below
is a non-pulsatile vein waveform (B)

Sample curser showing the angle in which blood flow is moving through the portal vein (A). A nonpulsatile waveform of the hepatic portal vein with the velocity of blood flow measured in cm/s located on
the right side of the image (B).
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Figure 14

Body weight (A) and heart girth (B) in offspring born to dams treated with
(MEL) or without melatonin (CON) during late gestation

An age by treatment interaction was observed for offspring body weight (P < 0.01) and
heart girth (P < 0.01). Asterisk (*) represents a significant difference (P < 0.05) between
treatment groups within a given age.
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Figure 15

Absolute hepatic portal bf (A), hepatic portal blood flow by bw (B), and
Insulin-like growth factor 1 (C) in offspring born to dams treated with
(MEL) or without melatonin (CON) during late gestation

No main effects of age (P = 0.06) or treatment (P = 0.94) were observed for absolute
hepatic portal blood flow. No main effects of age (P = 0.39) or treatment (P = 0.87) were
observed for hepatic portal blood flow by body weight. A main effect of age (P = 0.02)
was observed for IGF-1. Insulin-like growth factor 1 decreased from week 0 to 4 of age.
Insulin-like growth factor1 was not different among treatments (P = 0.43).
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Figure 16

Pulse pressure (A), mean arterial pressure (B), and heart rate (C) in
offspring born to dams treated with (MEL) or without melatonin (CON)
during late gestation

No main effects of age (P = 0.73) or treatment (P = 0.79) were observed for pulse
pressure. A main effect of age (P = 0.04) was observed for mean arterial pressure. Mean
arterial pressure was not different among treatments (P = 0.19). A main effect of age (P <
0.01) was observed for heart rate. Heart rate decreased as calf age increased. Heart rate
was not different among treatments (P = 0.26).
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Figure 17

Cortisol in offspring born to dams treated with (MEL) or without melatonin
(CON) during late gestation

An age by treatment interaction (P = 0.03) was observed for cortisol. Asterisk (*)
represents a significant difference (P < 0.05) between treatment groups within a given
age.
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Figure 18

Total antioxidant capacity and total nitrites in offspring born to dams
treated with (MEL) or without melatonin (CON) during late gestation

A main effect of age (P < 0.01) was observed for total antioxidant capacity. Total
antioxidant capacity peaks at week 1 and is lower at all other weeks. Total antioxidant
capacity was not different among treatments (P = 0.14). A main effect of age (P < 0.01)
was observed for nitrites, which peaked at week 1 and is lower at all other weeks. Nitrites
were not different across treatments (P = 0.69).
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